Lindbrook Capital’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$7.26K Buy
69
+6
+10% +$631 ﹤0.01% 1793
2024
Q4
$6.75K Hold
63
﹤0.01% 1845
2024
Q3
$6.31K Hold
63
﹤0.01% 1908
2024
Q2
$5.31K Buy
63
+8
+15% +$674 ﹤0.01% 1965
2024
Q1
$4.02K Hold
55
﹤0.01% 1993
2023
Q4
$3.93K Buy
+55
New +$3.93K ﹤0.01% 2012
2023
Q3
Sell
-20
Closed -$1.44K 2780
2023
Q2
$1.44K Hold
20
﹤0.01% 2279
2023
Q1
$1.47K Buy
+20
New +$1.47K ﹤0.01% 2360
2022
Q4
Sell
-93
Closed -$5K 2939
2022
Q3
$5K Buy
+93
New +$5K ﹤0.01% 1676
2020
Q2
Sell
-30
Closed -$1K 1823
2020
Q1
$1K Hold
30
﹤0.01% 1493
2019
Q4
$2K Hold
30
﹤0.01% 1298
2019
Q3
$2K Sell
30
-92
-75% -$6.13K ﹤0.01% 1271
2019
Q2
$8K Hold
122
﹤0.01% 950
2019
Q1
$9K Hold
122
﹤0.01% 922
2018
Q4
$10K Buy
+122
New +$10K ﹤0.01% 820